Testosterone replacement therapy has been touted as the key to male vitality, enhanced libido and physical performance. After all, this powerful male hormone helps guys maintain muscle mass, sperm production and the all-important sex drive. Some four percent of men in their 60’s are taking testosterone supplements, according to a... Read more »

The U.S. Food and Drug Administration has yet to approve any type of testosterone replacement therapy as a treatment for age-associated low testosterone levels, otherwise known as “Low T.” Yet manufacturers of testosterone supplements have aggressively marketed products like Androgel to thousands of middle aged American men who believed they... Read more »

A California resident is the most recent complainant in the ongoing federal court battle against Fresenius Medical Care (FMC), the world’s largest dialysis services and products company. Mr. Ronnie Miller, the Plaintiff, is the anticipated Administrator of the estate of Lula Brown, who died of sudden cardiac arrest in December,... Read more »

Mason v. Fresenius Medical Care Holdings, Inc. was filed directly into multidistrict litigation (MDL 2428) on December 10, 2014, joining thousands of similar claims that allege Granuflo and Naturalyte dialysis additives are defective and unreasonably dangerous. Plaintiff Robert Mason brought his product liability complaint individually and on behalf of the... Read more »

Amid concerns over testosterone therapy side effects, an FDA panel has backed limitations on labeling for testosterone to exclude prescriptions for men who take the therapy only to counteract ordinary signs of aging rather than specific hormonal abnormalities. The panel also voted overwhelmingly to require clinical safety trials for some... Read more »

Low T drug lawsuits alleging life-altering complications from Androgel, Testim and other testosterone supplements continue to mount in courtrooms across the nation. Plaintiffs claim they were inadequately warned about the risk of cardiovascular injury, stroke, heart attack and other severe health complications by the manufacturers of testosterone replacement products. A... Read more »

In what is likely a precursor to the Food and Drug Administration taking regulatory action on low testosterone replacement therapy (TRT), the FDA has asked two advisory committees to meet on September 17 to evaluate the risks and reported testosterone side effects linked to so-called “Low T” drugs, such as AndroGel, Testim,... Read more »

The makers of several testosterone supplements are facing an impending class action lawsuit filed in California District Court early last month. The testosterone class action lawsuit raises several counts against manufacturers of over-the-counter products containing the chemical Testofen and asserts many of the claims made by these manufacturers are bogus, exaggerated... Read more »